GLP-1 and Skin: Acne, Dryness, and Rashes — Why They Happen

Some people on GLP-1 medications notice their skin becoming drier, developing new breakouts, or experiencing rashes — while others report the opposite. Each of these changes has a distinct set of contributing factors, and the research on direct causal links to GLP-1 medications remains limited. This article breaks down what tends to happen with skin on a GLP-1, and what’s worth tracking for your provider.

Why Does Skin Feel Different on a GLP-1?

The skin is sensitive to a number of shifts that can accompany GLP-1 use — changes in appetite, dietary patterns, hydration habits, and hormone levels. These shifts don’t affect everyone the same way, and the skin response (if any) often varies considerably from person to person.

This article covers three types of skin-related reports that come up most often in GLP-1 communities: increased dryness, new or worsened acne, and rashes or itching. Each has a somewhat different set of contributing factors, which is why experiences can look so different from one person to the next.

In online GLP-1 communities, questions along the lines of Is anyone else dealing with really dry skin since starting? or breaking out way more than usual — anyone else? come up with some regularity. Understanding the possible mechanisms behind these types of experiences may help clarify what could be contributing.

If you’re also noticing changes in your hair, that’s covered separately — hair shedding on GLP-1 medications has its own set of mechanisms that are distinct from skin texture changes. The two are easy to conflate, but the skin changes described here involve different underlying processes.

Drier Skin — Why It Can Happen

Some people on GLP-1 medications notice drier skin, particularly on the face, hands, or lips. One contributing factor may be a reduction in dietary fat intake.

When appetite decreases significantly — as it often does on a GLP-1 — the overall amount of food eaten tends to drop, and this can include fats. The skin’s outer barrier relies partly on lipids to maintain its structure and water-retention capacity. If overall fat intake drops substantially over time, this may affect how well the skin retains moisture. This is not a direct medication effect — it tends to be a downstream effect of reduced appetite and changed eating patterns.

Hydration patterns can also shift. GLP-1 medications affect gastric emptying and can influence feelings of thirst in some people. If water intake decreases as part of broader appetite changes, skin hydration may follow. For more on hydration during GLP-1 use, this hydration overview covers common patterns and what many people find helpful.

A few observations from people managing dryness on a GLP-1:

• Many people find that applying a basic, unscented moisturizer after washing helps skin feel more comfortable. This is a general hygiene practice — not a treatment recommendation, and not a guarantee that it will address the underlying cause.
• Some people notice their lips becoming drier as well, which can be part of the same pattern.
• If dryness becomes persistent or causes significant discomfort, that is worth mentioning to a provider rather than assuming it will resolve on its own.

Acne and Skin Texture

Acne is one of the more frequently reported skin concerns in GLP-1 communities, and the research picture here is genuinely unclear.

A 2024 systematic review published in the International Journal of Women’s Dermatology — authored by Ogunremi OO, Ismail SF, Dhami RK, Newton JS, Kindle SA, and Kozmenko V — reviewed the available evidence and found no conclusive evidence that GLP-1 medications directly cause acne as a side effect.

This is an important context for what follows: when people report new or worsened breakouts while on a GLP-1, the direct causal link to the medication itself has not been established in the research literature.

What may be contributing instead:

Hormonal shifts associated with weight loss can affect sebum production. As weight changes, hormone levels — including androgens that regulate oil glands — can fluctuate. The skin’s sebaceous glands respond to these hormonal signals, and some people notice increased oiliness or breakouts during periods of significant weight change. This pattern has been observed in other weight-loss contexts well before GLP-1 medications existed.

Dietary pattern changes may also play a role. When appetite drops, food choices often shift, sometimes substantially. The relationship between diet and acne remains an active area of research, but this is a plausible contributing factor for some people.

Changes in skin care routines sometimes go overlooked. If nausea or fatigue during the early adjustment period leads someone to skip cleansing or alter their routine, the skin may respond.

A separate study published in Cureus — Jabin A, Khan S, Khan H, Durrani ZU, Hamza K, Gul F, Atta Ullah S, Dayam F, Yaseen M, and Shah S — followed 110 adults who specifically started semaglutide because of skin conditions including acne, hidradenitis suppurativa, or other sebaceous gland conditions. In this specific group, the researchers reported improvements in skin outcomes. This finding applies to that study population — adults who began semaglutide for skin management — and does not generalize to all GLP-1 users.

If you’re experiencing new or worsened acne that concerns you, a dermatologist visit is worthwhile — distinguishing between what may be related to the medication, to weight change, or to other factors is genuinely difficult without clinical assessment.

Rashes, Itching, and Reactions

Rashes and itching are worth separating into two distinct categories, because they have different implications and warrant different responses.

Injection site reactions — redness, minor swelling, itching, or a raised area at the injection site — are among the most commonly reported skin effects of injectable GLP-1 medications. These typically appear shortly after the injection and often resolve without intervention. Rotating injection sites among different areas (abdomen, thigh, upper arm) is a standard approach that many people find helps manage this pattern over time.

For more detail on injection site reactions — including what commonly resolves on its own versus what warrants medical attention — this article on injection site reactions covers the full picture.

Systemic rashes (rashes that appear away from the injection site, or that spread more broadly) represent a different situation. A widespread rash, hives, or significant itching that is not localized to the injection area should be evaluated by a provider. While uncommon, some people experience immune-mediated reactions that require medical assessment.

Generalized itching without a visible rash is also reported in GLP-1 communities. The possible explanations include changes in bile flow associated with rapid weight loss, dry skin becoming irritated, or other systemic effects. The range of possible causes is wide enough that self-assessment is not reliable — if itching is persistent or severe, this warrants a conversation with your provider.

The Other Direction: Why Some People Notice Clearer Skin

Not all skin changes during GLP-1 use run in the same direction. Some people report clearer skin, reduced skin inflammation, or improvements in conditions that were previously persistent.

A few possible explanations exist, though the evidence remains preliminary:

Dietary pattern improvements: When appetite decreases and eating patterns shift, some people find themselves eating differently than before — with less of the foods they personally associate with breakouts. Whether this translates to actual skin improvement varies considerably between individuals and is not well understood.

Hormonal rebalancing: In people with insulin resistance or conditions like polycystic ovary syndrome (PCOS), GLP-1 medications may affect hormone levels in ways that some research suggests could benefit skin conditions influenced by androgens. This is an active area of research rather than established clinical fact.

Possible anti-inflammatory effects: Some research suggests GLP-1 receptor agonists may have anti-inflammatory properties at a systemic level, though whether this consistently translates to meaningful skin benefits in the general population is not settled.

As noted in the acne section above, the Jabin and colleagues study followed adults who specifically began semaglutide because of skin conditions — a very different population from the typical GLP-1 user who begins the medication for metabolic or weight-related reasons. Generalizing from that study’s findings would go beyond what the data supports.

If you’re noticing clearer skin, that is worth recording in your log — but it also doesn’t confirm the medication is treating an underlying skin condition, and other contributing factors (dietary changes, stress reduction, seasonal variation) may be equally or more responsible.

What’s Worth Tracking About Your Skin

When skin changes are happening alongside other shifts in weight, appetite, and energy, it can be genuinely difficult to sort out what’s related to what. Keeping a basic log of when changes appear and what else was changing around the same time often turns out to be the most useful input you can bring to a provider visit.

A few things worth documenting if you’re experiencing skin changes:

• When the change started and how it has progressed since then
• Where it appears — injection site, face, body, or more widespread
• Whether it correlates with injection timing, dietary shifts, or other concurrent changes
• How your skin care routine has changed, if at all, since starting the medication
• Any products introduced or stopped around the same time the change appeared

The GLP-1 Side Effect and Progress Tracker lets you log symptoms with dates, which makes it easier to spot patterns and bring a coherent timeline to a provider visit rather than relying on memory.

For a broader overview of what tends to come up during GLP-1 use, the side effects overview covers the full range. If you’re new to tracking your experience, this guide on tracking your side effects walks through how to make the process useful rather than overwhelming.

When to Talk to Your Provider

The right moment to contact a provider isn’t always obvious, but certain patterns consistently warrant a call or visit rather than waiting:

• A rash that spreads beyond the injection site, covers a large area, or comes with fever or other systemic symptoms
• Significant skin changes that persist beyond a few weeks without any sign of resolving
• Severe or persistent itching, particularly if you don’t see an obvious localized cause
• Any skin change that appeared suddenly and is getting worse rather than better
• Acne that is severe, nodular, or causing scarring — this warrants dermatologist evaluation regardless of the medication context

Signs that are generally not emergencies but are worth mentioning at your next scheduled visit:

• Mild dryness or skin texture changes that are manageable
• Minor injection site reactions that resolve within a day or two
• Gradual changes in skin appearance that are not causing discomfort or distress

If you’re unsure whether what you’re seeing warrants prompt attention versus a next routine visit, your healthcare provider’s office is the right place to ask. Describing what you observe and when it appeared tends to be more useful than self-diagnosing from online descriptions — which is exactly why logging specifics matters.

At a Glance: Skin Reactions on GLP-1